The Prevalence of Gastroesophageal Reflux in Patients With Excessive Central Airway Collapse.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
03 2019
Historique:
received: 09 04 2018
revised: 10 09 2018
accepted: 24 09 2018
pubmed: 13 10 2018
medline: 21 12 2019
entrez: 13 10 2018
Statut: ppublish

Résumé

Gastroesophageal reflux (GER) is increasingly recognized as an exacerbating or causal factor in several respiratory diseases. There is a high prevalence of GER in infants with airway malacia. However, such data are lacking in adults. This retrospective study was conducted to determine the relationship between GER and excessive central airway collapse (ECAC). The study included consecutive patients with ECAC referred to the Complex Airway Center at Beth Israel Deaconess Medical Center who underwent esophageal pH testing for GER between July 2014 and June 2018. Sixty-three of 139 patients with ECAC (45.3%) had documented GER as shown by an abnormal esophageal pH test result. The mean DeMeester score was 32.2, with a symptom association probability of 39.7% of GER-positive patients. Twenty-nine of 63 patients (46%) with GER reported improvement in respiratory symptoms following maximal medical therapy or antireflux surgery without requiring further treatment for ECAC. GER is prevalent among patients with ECAC, and aggressive reflux treatment should be considered in these patients prior to considering invasive airway procedures or surgery.

Sections du résumé

BACKGROUND
Gastroesophageal reflux (GER) is increasingly recognized as an exacerbating or causal factor in several respiratory diseases. There is a high prevalence of GER in infants with airway malacia. However, such data are lacking in adults.
METHODS
This retrospective study was conducted to determine the relationship between GER and excessive central airway collapse (ECAC). The study included consecutive patients with ECAC referred to the Complex Airway Center at Beth Israel Deaconess Medical Center who underwent esophageal pH testing for GER between July 2014 and June 2018.
RESULTS
Sixty-three of 139 patients with ECAC (45.3%) had documented GER as shown by an abnormal esophageal pH test result. The mean DeMeester score was 32.2, with a symptom association probability of 39.7% of GER-positive patients. Twenty-nine of 63 patients (46%) with GER reported improvement in respiratory symptoms following maximal medical therapy or antireflux surgery without requiring further treatment for ECAC.
CONCLUSIONS
GER is prevalent among patients with ECAC, and aggressive reflux treatment should be considered in these patients prior to considering invasive airway procedures or surgery.

Identifiants

pubmed: 30312588
pii: S0012-3692(18)32561-3
doi: 10.1016/j.chest.2018.09.021
pmc: PMC6435905
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

540-545

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Références

Am J Respir Crit Care Med. 1998 Dec;158(6):1804-8
pubmed: 9847271
Gut. 2005 Dec;54(12):1810-7
pubmed: 16284291
Am J Gastroenterol. 2006 Nov;101(11):2619-28
pubmed: 16952280
Chest. 2005 Mar;127(3):984-1005
pubmed: 15764786
Am J Gastroenterol. 2009 Mar;104(3):553-9
pubmed: 19223881
Ann Thorac Surg. 2011 May;91(5):1574-80; discussion 1580-1
pubmed: 21377650
Dig Dis Sci. 1993 Aug;38(8):1402-8
pubmed: 8344094
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:11-30
pubmed: 21199510
Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Jun;30(6):1028-35
pubmed: 1507676
Chest. 2007 Aug;132(2):609-16
pubmed: 17699133
Am J Gastroenterol. 1974 Oct;62(4):325-32
pubmed: 4432845
Radiology. 2009 Jul;252(1):255-62
pubmed: 19420322
Gut. 2005 May;54(5):710-7
pubmed: 15831922
Eur Respir J. 1999 Dec;14(6):1266-70
pubmed: 10624753
Clin Radiol. 2013 Dec;68(12):1268-75
pubmed: 23953005
Gastroenterology. 2001 Jun;120(7):1599-606
pubmed: 11375942
J Gastrointest Surg. 2009 Aug;13(8):1440-7
pubmed: 19475461
Aliment Pharmacol Ther. 2013 Mar;37(5):555-63
pubmed: 23305085
Am J Med. 2000 Mar 6;108 Suppl 4a:120S-125S
pubmed: 10718464
Gut. 2014 Jun;63(6):871-80
pubmed: 23853213
J Thorac Imaging. 2011 Nov;26(4):278-89
pubmed: 22009081
Chest. 2001 Feb;119(2):409-13
pubmed: 11171716
Ann Am Thorac Soc. 2014 Jul;11(6):951-5
pubmed: 24960030
Acad Radiol. 2003 Jul;10(7):719-24
pubmed: 12862281
NCHS Data Brief. 2012 Jan;(82):1-8
pubmed: 22617494
Clin Chest Med. 2013 Sep;34(3):527-55
pubmed: 23993822
Chest. 1999 Aug;116(2):279-84
pubmed: 10453852
ORL J Otorhinolaryngol Relat Spec. 1976;38(3):178-86
pubmed: 945891
J Am Board Fam Pract. 2005 Sep-Oct;18(5):393-400
pubmed: 16148249
Pneumologie. 1995 Mar;49 Suppl 1:139-41
pubmed: 7617597
Am J Respir Crit Care Med. 2000 Jul;162(1):34-9
pubmed: 10903216
J Clin Sleep Med. 2016 Jan;12(1):87-94
pubmed: 26446244
Chest. 1993 Jun;103(6):1662-9
pubmed: 8404082

Auteurs

Adnan Majid (A)

Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: amajid@bidmc.harvard.edu.

Fayez Kheir (F)

Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Daniel Alape (D)

Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Michael Kent (M)

Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Anthony Lembo (A)

Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Vikram V Rangan (VV)

Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Megan Carreiro (M)

Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Sidhu P Gangadharan (SP)

Division of Thoracic Surgery and Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH